The determination of norepinephrine and epinephrine in plasma by HPLC with amperometric detection was modified, giving detection limits of 25 ng/1 and 18 ng/1 for norepinephrine and epinephrine, respectively, using l ml plasma. In order to achieve this sensitivity,* it was necessary to minimize the background noise by modification of Instrumentation and specimen handling. Particularly important was the extra purification of the reagents, the application of micro-bore HPLC, the enzymatic cleavage of uric acid and temperature control of the amperometric cell and the amplifier. Comparison of the present method with the radioenzymatic determination of catecholamines resulted in coefficients of correlation of r = 0.924 and 0.919 for norepinephrine and epinephrine, resp. (n = 38). The concentrations of the 38 different samples used for the comparison were in the physiological ränge.
n o uc on plasma are used. Moreover, there are great differenThe determination of catecholamines in plasma by ces in the concentrations determined by HPLC with HPLC and amperometric detection has been de-amperometric detection versus those measured with scribed by several authors (for review see 1. c. (1) (2) (3) (4) (5) (6) . a radioenzymatic method (7) . The aim of the present They have used sample volumes ranging from 0.75 study was the development of a method for the deterto 4 ml of plasma for each determination, The sensi-mination of norepinephrine and epinephrine in tivity of these methods is inadequate for determina-plasma which combines both simple handling and tion of resting values of epinephrine, even if 4 ml of sufficient sensitivity.
This goal seemed to be reasonable in view of the fact that an electrochemical method requires no tritiated compounds and is more amenable to mechanization (thereby increasing sample frequency) than the time consuming radioenzymatic method.
Methods

Principle of the method
The catecholamines are separated from the plasma matrix by adsorption on alumina at a high pH followed by selective desorption using a mixture of boric and acetic acid. The Separation and quantification of the extracted catecholamines is performed by micro-bore HPLC with amperometric detection. As uric acid is eluted at the front of the chromatogram, the enzymatic cleavage of uric acid is performed to avoid interference with norepinephrine.
Equipment
Details of the measuring equipment have been described by Bauersfeld et al. (8) .
Chemicals and reagents
Alumina, neutral 70-200 mesh (Merck, Darmstadt), was purified and activated s described by Anton & Sayre (9) . Sodium sulphate p. a. (Merck) was extracted with a solution of dithizon in Chloroform to remove traces of heavy metals. Boric acid p. a. (Merck): a saturated solution of boric acid was extracted with ethyl acetate and recrystallised. Water was purified.by distilling over sodium permanganate. Solutions were prepared acc. to Bauersfeld et al. (8) .
Methodology
To l ml of plasma were added 100 μΐ of solution B (8), 100 μΐ of 2 mol/1 Tris solution and 50 μΐ of 20 U/l uricase solution. After 10 min, 10 mg of alumina were added and cautiously mixed for 15 min using an inverting mixer. Next, the samples were centrifuged at 15000g for 30s. The upper layer was aspirated and discarded. The alumina was then washed twice with 500 μΐ of solution F. A final washing was performed with 500 μΐ of water. Following centrifugation, the washing solution was drawn off once again. Following the addition of 50 μΐ of solution E, the samples were agitated for 5 min, then centrifuged at 15000g for 2 min, after which each solution was transferred to another Eppendorf vial. These eluates were then stored at 4 °C until HPLC measurement. A final centrifugation at 15000g for 2min was performed immediately preceding injection of 20 μΐ of the eluates.
The HPLC Separation was performed using a micro-bore column; mobile phase: 42 mmol/1 acetic acid, l mmol/1 butylamine, 0.8 mmol/1 sodium octylsulphonate, 0.05 mmol/1 disodium-EDTA, 10 mmol/1 sodium sulphate. The flow rate was 300 μΐ/ min. The amperometric detector was set to an oxidizing potent ial of 650 mV and a sensitivity of 0.5 nA at f ll scale. The recovery of each sample was determined using the peak heights of the internal Standards (3,4-dihydroxybenzylamine or epinine).
Radioenzymatic method
For the comparative radioenzymatic measurements the method of Ratge et al. (10) was used.
Results and Discussion
The within-run and between-run precision was estimated by n = 10 measurements of plasma samples containing the catecholamines in physiological concentrations (tab. 1). The results are c mparable to those obtained with the radioenzymatic method used routinely in our laboratqry (10) . The recovery of norepinephrine was 99.1% (r nge 83.1 -106.9%) and of epinephrine 96.0% (r nge 88.2-109.3%). The linear measuring r nge was 40 to 1200 ng/1 for norepinephrine and 20 to 1200 ng/1 for epinephrine, resp. Thirty eight different serum samples were analysed with the present method and with the radioenzymatic method. The concentration of catecholamines in these samples were in the physiological r nge Specificity A large n mber of compounds were added, in order to evaluate their potential interference with the.determination of norepinephrine and epinephrine. No interference by any of the tested compounds (normetanephrine, metanephrine, 3-methoxytyramine, 3-methoxy-4-hydroxyphenylglycol, vanilmandelic acid, homovanillic acid, tyramine, octopamine, synephrine, 3,4-dihydroxymandelic acid, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylglycol, serotonin, kynurenine, 3-hydroxykynurenine and tryptamine) was observed.
Sensitivity
The detection limit was estimated to be 25 ng/1 and 18 iig/1 for norepinephrine and epinephrine, resp., when defmed s the concentration equivalent to three times the baseline noise. * * To compare the sensitivity of our method with that of other publications that define the detection limit äs three times the baseline noise of aqueous catecholamine Solutions, we obtained values of 3.5 pg norepinephrine and 4.0 pg epinephrine, for the detection limits.
Practicability
The time required for each chromatogram was 30 min. The sample freqüeiicy was determined to be 40 samples/day, presuming the use of a programmecontrolled sample injeetor. Pre-purification of 12 samples required about one hour and the evaluation of the chromatograms an additional hoür.
Clinical application of the method
The· sensitivity of the presented method is adequate for measuring norepinephrine and epinephrine in the ränge of physiolpgical plasma concentrations. A typical chromatogram of a sample frpm a healthy volunteer is shown in figure 2 (left) . The marked peaks correspond to concentrations of 194 ng/1 and 57 ng/1 of norepinephrine and epinephrine, resp. A chromatogram of a sample from a patient with a phaeochromocytoma is shown in figure 2 (right) . The peaks correspond to concentrations of 1292 ng/1 and 1023 ng/1 of norepinephrine and epinephrine, resp. The increase in sensitivity of the present method results from several modifications to instrumentatipn and handling. The use of a micro-bore column permitting low flow rates, of a detector capable of controlling the temperature of the thin layer cell, and of an amplifier generating reduce.d electronic noise results in a significant increase in the sensitivity of the method. As the Separation of norepinephrine from uric acid by HPLC is generally difficult, enzymatic cleavage of uric acid is utilized to avoid this Chromatographie problem. The elution of catecholamines from alumina by a mixture of boric and acetic acid also increases the selectivity of the method. This is demonstrated by the fact that the interferences with epinephrine and 3,4-dihydroxybenzylamine which can be observed by elution with perchloric acid, are not observed when a mixture of boric acid and acetic acid is employed.
Dual electrochemical detectors (11) may be more selective than simple amperometric detectors, but it was impossible to separate interferants like uric acid in this way.
The excellent correlation of the two methods evaluated in the present study demonstrates the necessity of the described modifications.. ( It should also be remembered that each measurement presented in this study was accomplished using a sample volume of l ml, which is a quarter of the volume required in most previously published procedures.
Another advantage of this method is the simplified handling compared with radioenzymatic methods. A sample frequency of 40 samples per day can be achieved with 8 hours being needed for the pre-purification of the samples and the final evaluation of the chromatograms. If samples from differeiit patients are estimated by the radioenzymatic method, enzymatic recovery must be determined for each sample, and oiily 25 samples can be measured in 12 höurs over two day s.
